Vuzix (VUZI) 10-Q 9 Nov 17 2017 Q3 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	9 Months Ended
	Sep. 30, 2017	Nov. 09, 2017
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2017
Document Fiscal Year Focus	2,017
Document Fiscal Period Focus	Q3
Entity Registrant Name	Vuzix Corp
Entity Central Index Key	1,463,972
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer
Trading Symbol	VUZI
Entity Common Stock, Shares Outstanding		22,203,911

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($)	Sep. 30, 2017	Dec. 31, 2016
Current Assets
Cash and Cash Equivalents	$ 8,677,341	$ 14,533,944
Accounts Receivable	470,484	103,314
Subscription Receivable from Officer	61,000	0
Accrued Project Revenue	687,001	0
Inventories, Net	2,842,591	2,651,218
Manufacturing Vendor Prepayments	117,524	144,168
Prepaid Expenses and Other Assets	762,679	797,409
Total Current Assets	13,618,620	18,230,053
Long-Term Assets
Fixed Assets, Net	3,885,605	3,364,908
Patents and Trademarks, Net	632,740	535,461
Software Development Costs, Net	329,204	214,838
Total Assets	18,466,169	22,345,260
Current Liabilities
Accounts Payable	1,819,950	1,085,472
Current Portion of Long-Term Debt, net of discount	0	1,416,480
Customer Deposits	63,589	66,162
Unearned Revenue	117,330	509,572
Accrued Expenses	1,160,765	1,331,983
Derivative Liability	122,533	0
Income and Other Taxes Payable	6,665	12,290
Total Current Liabilities	3,290,832	4,421,959
Long-Term Liabilities
Derivative Liability	0	173,131
Accrued Expenses	20,832	28,333
Total Long-Term Liabilities	20,832	201,464
Total Liabilities	3,311,664	4,623,423
Stockholders’ Equity
Preferred Stock — $.001 Par Value, 5,000,000 Shares Authorized; 49,626 Shares Issued and Outstanding September 30, 2017, and December 31, 2016	50	50
Common Stock — $.001 Par Value, 100,000,000 Shares Authorized; 22,178,911 Shares Issued and Outstanding September 30, 2017 and 19,569,247 on December 31, 2016	22,178	19,569
Additional Paid-in Capital	105,725,265	94,541,168
Accumulated Deficit	(90,592,988)	(76,838,950)
Total Stockholders’ Equity	15,154,505	17,721,837
Total Liabilities and Stockholders’ Equity	$ 18,466,169	$ 22,345,260

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Sep. 30, 2017	Dec. 31, 2016
Preferred Stock, Par Value	$ 0.001	$ 0.001
Preferred Stock, Shares Authorized	5,000,000	5,000,000
Preferred Stock, Shares Issued	49,626	49,626
Preferred Stock, Shares Outstanding	49,626	49,626
Common Stock, Par Value	$ 0.001	$ 0.001
Common Stock, Shares Authorized	100,000,000	100,000,000
Common Stock, Shares Issued	22,178,911	19,569,247
Common Stock, Shares Outstanding	22,178,911	19,569,247

CONSOLIDATED STATEMENT OF CHANG

CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS’ EQUITY - 9 months ended Sep. 30, 2017 - USD ($)	Total	Preferred Stock	Common Stock	Additional Paid-in Capital	Accumulated Deficit
Balance at Dec. 31, 2016	$ 17,721,837	$ 50	$ 19,569	$ 94,541,168	$ (76,838,950)
Balance (in shares) at Dec. 31, 2016		49,626	19,569,247
Conversion of Note Payable & Accrued Interest	1,861,283		$ 827	1,860,456
Conversion of Note Payable & Accrued Interest (in shares)			827,237
Exercise of Warrants	0		$ 168	(168)
Exercise of Warrants (in shares)			168,203
Stock Based Compensation Expense	912,102		$ 10	912,092
Stock Based Compensation Expense (in shares)			10,420
Exercise of Stock Options	0		$ 37	(37)
Exercise of Stock Options (in shares)			37,261
Common Stock Issued for Services	100,000		$ 17	99,983
Common Stock Issued for Services (in shares)			16,543
Common Stock Awards to Directors	335,000		$ 50	334,950
Common Stock Awards to Directors (in shares)			50,000
Proceeds from Common Stock Offerings	8,628,500		$ 1,500	8,627,000
Proceeds from Common Stock Offerings (in shares)			1,500,000
Direct Costs of Common Stock Offerings	(650,179)			(650,179)
Net Loss for the Nine Months Ended September 30, 2017	(13,754,038)				(13,754,038)
Balance at Sep. 30, 2017	$ 15,154,505	$ 50	$ 22,178	$ 105,725,265	$ (90,592,988)
Balance (in shares) at Sep. 30, 2017		49,626	22,178,911

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Sales of Products	$ 1,138,413	$ 582,549	$ 3,002,744	$ 1,367,766
Sales of Engineering Services	266,687	0	938,281	139,500
Total Sales	1,405,100	582,549	3,941,025	1,507,266
Cost of Sales - Products	1,089,881	819,116	3,441,650	2,069,964
Cost of Sales - Engineering Services	407,220	0	872,137	39,060
Total Cost of Sales	1,497,101	819,116	4,313,787	2,109,024
Gross Loss (exclusive of depreciation shown separately below)	(92,001)	(236,567)	(372,762)	(601,758)
Operating Expenses:
Research and Development	1,506,307	2,177,957	4,374,202	5,121,713
Selling and Marketing	908,797	839,497	2,739,978	2,627,543
General and Administrative	1,612,542	1,274,698	4,155,960	3,350,441
Depreciation and Amortization	251,366	196,370	734,175	549,244
Loss on Inventory Revaluation	1,151,482	0	1,151,482	0
Loss from Operations	(5,522,495)	(4,725,089)	(13,528,559)	(12,250,699)
Other Income (Expense)
Investment Income	12,956	8,144	45,800	20,923
Other Taxes	(15,734)	(19,124)	(37,884)	(53,749)
Foreign Exchange Loss	(5,246)	(13,781)	(30,299)	(21,267)
Gain (Loss) on Derivative Valuation	41,454	(59,120)	50,598	(57,133)
(Loss) on Fixed Asset Disposal	(585)	(25,890)	(585)	(25,890)
Amortization of Senior Term Debt Discount	0	(155,313)	(155,760)	(391,334)
Amortization of Deferred Financing Costs	0	(11,707)	(19,500)	(34,867)
Interest Expense	(12,592)	(33,981)	(77,849)	(101,075)
Total Other Income (Expense)	20,253	(310,772)	(225,479)	(664,392)
Loss Before Income Taxes	(5,502,242)	(5,035,861)	(13,754,038)	(12,915,091)
Provision (Benefit) for Income Taxes	0	0	0	0
Net Loss	(5,502,242)	(5,035,861)	(13,754,038)	(12,915,091)
Preferred Stock Dividends	(435,321)	(410,153)	(1,273,029)	(1,203,693)
Loss Attributable to Common Stockholders	$ (5,937,563)	$ (5,446,014)	$ (15,027,067)	$ (14,118,784)
Loss per Share
Basic and Diluted Loss per Share	$ (0.28)	$ (0.32)	$ (0.73)	$ (0.86)
Weighted-average Shares Outstanding Basic and Diluted	21,366,712	17,216,374	20,515,363	16,489,522

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Cash Flows from Operating Activities
Net Loss	$ (13,754,038)	$ (12,915,091)
Non-Cash Adjustments
Depreciation and Amortization	734,175	549,244
Amortization of Software Development Costs in cost of sales products	214,838	214,836
Stock Based Option Compensation Expense	912,102	540,843
Common Stock Awards Compensation Expense	83,750	174,025
Loss on Disposal of Fixed Assets	585	25,890
Amortization of Term Debt Discount	155,760	391,334
Amortization of Debt Issuance Costs	19,500	34,867
Common Stock Issued for Services	100,000	241,300
(Gain) Loss on Derivative Valuation	(50,598)	57,133
Loss on Inventory Valuation	1,151,482	0
(Increase) Decrease in Operating Assets
Accounts Receivable	(367,170)	206,409
Accrued Revenue	(687,001)	0
Inventories	(1,342,855)	(623,445)
Vendor Prepayments	26,644	163,471
Prepaid Expenses and Other Assets	285,980	(223,135)
Increase (Decrease) in Operating Liabilities
Accounts Payable	734,478	622,119
Accrued Expense	253,398	311,291
Customer Deposits	(2,573)	15,536
Unearned Revenue	(392,242)	300,796
Income and Other Taxes Payable	(5,626)	16,764
Accrued Compensation	(240,110)	0
Accrued Interest	77,537	(142,347)
Net Cash Flows Used in Operating Activities	(12,091,984)	(10,038,160)
Cash Flows from Investing Activities
Purchases of Fixed Assets	(1,197,452)	(1,551,141)
Investments in Patents and Trademarks	(155,284)	(103,375)
Investments in Software Development	(329,204)	0
Net Cash Used in Investing Activities	(1,681,940)	(1,654,516)
Cash Flows from Financing Activities
Proceeds from Exercise of Warrants	0	45,000
Repayment of Long-Term Debt and Notes Payable	0	(52,416)
Proceeds from Common Stock Offerings	8,567,500	6,612,500
Direct Costs from Common Stock Offerings	(650,179)	(847,805)
Net Cash Flows Provided by Financing Activities	7,917,321	5,757,279
Net Decrease in Cash and Cash Equivalents	(5,856,603)	(5,935,397)
Cash and Cash Equivalents — Beginning of Period	14,533,944	11,877,058
Cash and Cash Equivalents — End of Period	8,677,341	5,941,661
Supplemental Disclosures
Interest Paid in Cash	310	7,860
Conversion of Debt and Accrued Interest	1,861,283	342,034
Subscription Receivable from Officer	$ 61,000	$ 0

Basis of Presentation

Basis of Presentation	9 Months Ended
	Sep. 30, 2017
Organization, Consolidation and Presentation Of Financial Statements [Abstract]
Basis of Presentation	Note 1 — Basis of Presentation The accompanying unaudited Condensed Consolidated Financial Statements of Vuzix Corporation and Subsidiaries (“the Company") have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Regulation S-X of the Securities and Exchange Commission. Accordingly, the unaudited Condensed Consolidated Financial Statements do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. The condensed consolidated balance sheet as of December 31, 2016 was derived from the audited Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016 (the “Annual Report”). The accompanying Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements of the Company as of December 31, 2016, as reported in the Company’s Annual Report. The results of the Company’s operations for any interim period are not necessarily indicative of the results of the Company’s operations for any other interim period or for a full fiscal year. For the nine months ended September 30, 2017, Toshiba Japan represented substantially all of engineering revenues and 24 0 59 0 The accompanying Condensed Consolidated Financial Statements have been prepared assuming that we will continue as a going concern. This basis of accounting contemplates the recovery of our assets and the satisfaction of liabilities in the normal course of business. These Condensed Consolidated Financial Statements do not include any adjustments to the specific amounts and classifications of assets and liabilities, which might be necessary should we be unable to continue as a going concern. The Company incurred a net loss for the nine months ended September 30, 2017 of $ 13,754,038 19,250,082 13,427,478 90,592,988 The Company’s cash requirements are primarily for funding operating losses, research, capital expenditures and working capital. Historically, the Company has met these cash needs by borrowings under notes, sales of convertible debt, and the sales of equity. In 2016, we received total net proceeds from public equity offerings of $ 19,238,015 1,490,000 5.75 As part of the same offering, we sold an additional 10,000 6.10 of $ 61,000 7,978,321 Our cash requirements related to funding operating losses depend upon numerous factors, including new product development activities, our ability to commercialize our products, our products’ timely market acceptance, selling prices and gross margins, and other factors. In order for us to achieve positive cash flow from operations, our product sales will need to significantly increase The Company’s management intends to take actions necessary to continue as a going concern, as discussed herein. The Company will need to grow its business significantly to become profitable and self-sustaining on a cash flow basis. Management’s plans concerning these matters and managing our liquidity include among other things: ⋅ the commencement of full and higher volume manufacturing of the new M300 Smart Glasses with assembly offshore in the summer of 2017, on a turnkey basis, which should result in further product margin improvements and supply chain investments, as demonstrated in our third quarter; ⋅ the award of a Smart Glasses development program with Toshiba, which we expect to be completed by end of 2017 and represents approximately a further $ 221,000 which thereafter should move into volume production in early 2018 with a proposed supply and purchase agreement that we expect will result in a minimum of $ 5,000,000 ⋅ tighter control of operating costs and reduction in spending growth rates wherever possible; ⋅ slowing of planned new product development based on new technologies as well as reduced discretionary and non-essential capital expenditures not related to select near-term new products ⋅ reducing the rate of research and development spending on new technologies, particularly the use of costly external contractors, for our upcoming smart glasses models that will first be manufactured at our Rochester plant rather than at external contractors, where we incur high start-up costs and the requirement for bigger production commitments that consume working capital; ⋅ better leveraging our product and technology base and creating new product models that are derivatives (rather than completely new) and which therefore are less costly to develop and introduce to the marketplace; and ⋅ attempting to utilize conventional bank operating loan financing to help grow our working capital base to support our investments in accounts receivable and inventory as sales revenues grow. However, if these actions are not successful in the near term, we will have to raise additional capital to maintain operations and/or materially reduce our operating and new product development costs. If the Company raises additional funds by selling equity, the ownership interest of existing stockholders may be diluted. The amount of such dilution could increase further due to the issuance of securities with new warrants or convertibility features with other dilutive characteristics, such as anti-dilution clauses or price resets Based upon our current amount of cash on hand, management’s historical ability to raise capital, and our ability to manage our cost structure and adjust operating plans if and as required, we have concluded that substantial doubt of our ability to continue as a going concern has been alleviated.

Loss Per Share

Loss Per Share	9 Months Ended
	Sep. 30, 2017
Earnings Per Share [Abstract]
Loss Per Share	Note 2 – Loss Per Share Basic loss per share is computed by dividing the loss attributable to common stockholders by the weighted average number of common shares outstanding for the period. Diluted earnings per share reflects the potential dilution from the assumed exercise of stock options and warrants, and the conversion of any convertible debt and convertible preferred shares. During periods of net loss, all common stock equivalents are excluded from the diluted EPS calculation because they are antidilutive. Since the Company reported a net loss for the three and nine months ended September 30, 2017 and 2016, the calculation for basic and diluted earnings per share is considered to be the same, as the impact of potential common shares is anti-dilutive. As of September 30, 2017 and December 31, 2016, there were 6,532,259 7,227,738

Inventories, Net

Inventories, Net	9 Months Ended
	Sep. 30, 2017
Inventory Disclosure [Abstract]
Inventories	Note 3 — Inventories, Net September 30, December 31, Purchased Parts and Components $ 2,069,378 $ 1,990,026 Work in Process 212,444 454,120 Finished Goods 1,217,700 831,069 Less: Reserve for Obsolescence (656,931) (623,997) Net $ 2,842,591 $ 2,651,218 In addition to its normal Reserve for Obsolescence provision, the Company wrote-down to net realizable value all of its component and finished goods inventory related to its iWear Video Headphones, as well as accrued all related contractual obligations, resulting from the decision in the third quarter of 2017 to reduce the suggested retail selling price to a price below the cost. The loss totaled $ 1,151,482

Accrued Expenses

Accrued Expenses	9 Months Ended
	Sep. 30, 2017
Payables and Accruals [Abstract]
Accrued Expenses	Note 4 — Accrued Expenses September 30, December 31, Accrued Wages and Related Costs $ 169,047 $ 119,472 Accrued Officer Compensation 408,609 648,720 Accrued Professional Services 275,500 137,099 Accrued Warranty Obligations 114,056 41,132 Accrued Interest 183,553 375,560 Other Accrued Expenses 10,000 10,000 Total $ 1,160,765 $ 1,331,983 Included in the above accrued compensation are amounts owed to officers of the Company for services rendered that remain outstanding primarily for 2016 and prior years. The amounts are not subject to a fixed repayment schedule and they bear interest at a rate of 8 183,553 141,645 The Company has warranty obligations in connection with the sale of certain of its products. The warranty period for its products is generally one year except in certain European countries where it is two years for some products. The costs incurred to provide for these warranty obligations are estimated and recorded as an accrued liability at the time of sale. The Company estimates its future warranty costs based on product-based historical performance rates and related costs to repair. Accrued Warranty Obligations at December 31, 2016 $ 41,132 Reductions for Settling Warranties (102,260) Warranties Issued During Period 175,184 Accrued Warranty Obligations at September 30, 2017 $ 114,056

Derivative Liability and Fair V

Derivative Liability and Fair Value Measurements	9 Months Ended
	Sep. 30, 2017
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Liability and Fair Value Measurements	Note 5 – Derivative Liability and Fair Value Measurements The Company recognized a derivative liability for the warrants to purchase shares of its common stock issued in connection with the equity offering and related debt conversions on August 5, 2013. These warrants have a cashless exercise provision and an exercise price that is subject to adjustment in the event of subsequent equity sales at a lower purchase price (subject to certain exceptions) along with full-ratchet anti-dilution provisions. In accordance with FASB ASC 815-10-25, we measured the derivative liability using a Monte Carlo Options Lattice pricing model at their issuance date and subsequently remeasured the liability on each reporting date. Accordingly, at the end of each quarterly reporting date, the derivative fair market value is remeasured and adjusted to current market value. As of September 30, 2017 and December 31, 2016 a total of 38,100 86 The Company recognized a derivative liability during the year ended December 31, 2014 for the $ 3,000,000 1,938,988 The Company has adopted FASB ASC Topic 820 for financial instruments measured at fair value on a recurring basis. FASB ASC Topic 820 defines fair value, establishes a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. FASB ASC Topic 820 establishes a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include: - Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; - Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and - Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. The carrying amount of cash, accounts receivable, accounts payable, and accrued expenses approximates their fair value due to their short maturity. The carrying amount of notes payable approximates fair value because stated or implied interest rates approximate current interest rates that are available for debt with similar terms. We measure certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis are as follows at September 30, 2017: Total Level 1 Level 2 Level 3 Derivative Liability $ 122,533 $ — $ — $ 122,533 Total liabilities measured at fair value (Current liabilities) $ 122,533 $ — $ — $ 122,533 We measure certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis are as follows at December 31, 2016: Total Level 1 Level 2 Level 3 Derivative Liability $ 173,131 $ — $ — $ 173,131 Total liabilities measured at fair value (Long-Term) $ 173,131 $ — $ — $ 173,131 Fair value – December 31, 2016 $ 173,131 Change in fair value for the period of warrant derivative liability (50,598) Fair value – September 30, 2017 $ 122,533 September 30, December 31, 2017 2016 Assumptions for Pricing Model: Expected term in years 0.85 1.22 Volatility range for years 61 % 100 % Risk-free interest rate 1.31 % 1.47 % Expected annual dividends None None Value of warrants outstanding: Fair value of warrants $ 122,533 $ 173,131

Long-Term Debt

Long-Term Debt	9 Months Ended
	Sep. 30, 2017
Debt Disclosure [Abstract]
Long-Term Debt	Note 6 — Long-Term Debt September 30, December 31, 2017 2016 Convertible, Senior Secured Notes payable. The principal was due June 3, 2017 and no payments were required prior to maturity. The notes carried a 5% annual interest rate, payable upon the notes’ maturity. Both the principal plus accrued interest were convertible into shares of the Company’s common stock at $2.25, subject to normal adjustments. The notes were secured by a first security position in all the assets of the Company. $ — $ 1,591,740 Convertible, Senior Secured Notes Debt Issuance Costs of $139,340, net of accumulated amortization. — (19,500) Unamortized debt discount related to derivative liability associated with above notes’ conversion price that was subject to adjustment in the event of subsequent equity sales at a lower purchase price (subject to certain exceptions). Upon issuance on June 3, 2014 the discount was $1,938,988. — (155,760) $ — $ 1,416,480 Less: Amount Due Within One Year — (1,416,480) Amount Due After One Year $ — $ — All of the $ 1,591,740 707,440 269,543 119,797

Income Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2017
Income Tax Disclosure [Abstract]
Income Taxes	Note 7 — Income Taxes The Company’s effective income tax rate is a combination of federal, state and foreign tax rates and differs from the U.S. statutory rate due to taxes on foreign income, permanent differences including tax-exempt interest, and the resolution of tax uncertainties, offset by a valuation allowance against U.S. deferred income tax assets.

Capital Stock

Capital Stock	9 Months Ended
	Sep. 30, 2017
Stockholders' Equity Note [Abstract]
Capital Stock	Note 8 — Capital Stock Preferred stock The Company may issue shares of undesignated preferred stock in one or more series. The Board of Directors is authorized to establish and designate the different series and to fix and determine their voting powers and other special rights and qualifications. A total of 5,000,000 49,626 49,626 On January 2, 2015 the Company closed a sale of Series A Preferred Stock to Intel Corporation (the “Series A Purchaser”), pursuant to which we issued and sold an aggregate of 49,626 500 24,813,000 Each share of Series A Preferred Stock is entitled to receive dividends at a rate of 6 4,407,158 3,134,129 The Series A Purchaser has the right, but not the obligation, to participate in any proposed issuance by the Company of its securities, subject to certain exceptions and in such amount as is sufficient to maintain the Series A Purchaser’s ownership percentage in the Company, calculated immediately prior to such applicable financing, at a purchase price equal to the per share price of the Company’s securities in such applicable financing. In connection with the Series A Private Placement, the Company entered into an investor’s rights agreement with the Series A Purchaser, pursuant to which the Company agreed to file a “resale” registration statement with the Securities and Exchange Commission (the “SEC”) covering all the resale of shares of common stock issuable upon conversion of the Series A Preferred Stock. The Company’s registration statement covering the resale of these shares was declared effective by the SEC on February 17, 2015. Common Stock The Company’s authorized common stock consists of 100,000,000 0.001 22,178,911 19,569,247

Stock Warrants

Stock Warrants	9 Months Ended
	Sep. 30, 2017
Stockholders' Equity Note [Abstract]
Stock Warrants	Note 9 — Stock Warrants Number of Warrants Warrants Outstanding at December 31, 2016 401,859 Exercised During the Period (250,009) Issued During the Period — Expired During the Period — Warrants Outstanding, September 30, 2017 151,850 The outstanding warrants as of September 30, 2017 expire from November 3, 2017 to August 5, 2018. The weighted average remaining term of the warrants is 0.7 2.66

Stock Based Compensation Plans

Stock Based Compensation Plans	9 Months Ended
	Sep. 30, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Stock Based Compensation Plans	Note 10 — Stock Based Compensation Plans Weighted Average Number of Exercise Options Price Outstanding at December 31, 2016 1,084,298 $ 4.76 Granted 427,500 6.00 Exercised (63,187) 2.89 Expired or Forfeited (30,802) 9.35 Outstanding at September 30, 2017 1,417,809 $ 5.00 The weighted average remaining contractual term for all options as of September 30, 2017 and December 31, 2016 was 7.7 7.6 As of September 30, 2017, there were 716,046 4.63 6.7 As of September 30, 2017, there were 701,763 5.41 8.7 For the nine months ended September 30, 2017, all options exercised were on a cashless basis. The weighted average fair value of option grants was calculated using the Black-Scholes-Merton option pricing method. At September 30, 2017, the Company had approximately $ 3,512,000 3.0 During the nine months ended September 30, 2017, the Company issued 100,000 5.90 590,000 531,000 3.6 For the three months ended September 30, 2017 and 2016, the Company recorded total stock compensation expense of approximately $ 425,000 192,000 912,000 541,000

Litigation

Litigation	9 Months Ended
	Sep. 30, 2017
Litigation Disclosure [Abstract]
Litigation	Note 11 — Litigation We are not currently involved in any actual or pending legal proceeding or litigation and we are not aware of any such proceedings contemplated by or against us or our property .

Contractual Obligations

Contractual Obligations	9 Months Ended
	Sep. 30, 2017
Contractual Obligations [Abstract]
Contractual Obligations	Note 12 — Contractual Obligations The Company is party to several lease agreements, with the largest being for its office and manufacturing facility under an operating lease that commenced October 3, 2015 October 3, 2020 Total Minimum Lease Payments 2017 (3 months remaining) $ 93,053 2018 $ 348,900 2019 $ 341,990 2020 $ 307,311 2021 — Total $ 1,091,254 Under the lease agreements described above, the Company is required to pay the pro rata share of the real property taxes and assessments, expenses and other charges associated with these facilities. Rent expense for the nine months ended September 30, 2017 and 2016 totaled $ 344,227 371,239

Recent Accounting Pronouncement

Recent Accounting Pronouncements	9 Months Ended
	Sep. 30, 2017
Accounting Changes and Error Corrections [Abstract]
Recent Accounting Pronouncements	Note 13 — Recent Accounting Pronouncements In May 2014, the FASB issued ASU 2014-09, “ Revenue from Contracts with Customers, In February 2016, the FASB issued Accounting Standards Update ASU 2016-02 Leases Accounting Pronouncements Adopted in Q1 2017 In March 2016, the FASB issued ASU No. 2016-09 Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting In November 2015, the FASB issued Accounting Standards Update (“ASU”) No. 2015-17, Income Taxes (Topic 740): Balance Sheet Classification of Deferred Taxes There are no other recent accounting pronouncements that we expect to have a material impact on the consolidated financial statements.

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2017
Subsequent Events [Abstract]
Subsequent Events	Note 14 — Subsequent Events Subsequent to September 30, 2017, the Company entered into Technology Acquisition Agreement where it acquired all the seller's right, title and interest in certain Transferred Intellectual Property (IP). Pursuant to the agreement, the Company will pay approximately $75,702 as reimbursement of related patent applications to date. Further the Company will issue up to a total of 100,000 restricted shares of common stock as follows (i) 25,000 shares shall be issued upon the closing; (ii) a further 25,000 shares after the Company has successfully developed a working demonstrator system utilizing the IP; and (iii) 50,000 shares once the Company completes the successful commercialization of products containing the IP for sale in the marketplace. 200,000

Inventories, Net (Tables)

Inventories, Net (Tables)	9 Months Ended
	Sep. 30, 2017
Inventory Disclosure [Abstract]
Schedule of Inventories	Inventories are stated at the lower of cost and net realizable value and consisted of the following: September 30, December 31, Purchased Parts and Components $ 2,069,378 $ 1,990,026 Work in Process 212,444 454,120 Finished Goods 1,217,700 831,069 Less: Reserve for Obsolescence (656,931) (623,997) Net $ 2,842,591 $ 2,651,218

Accrued Expenses (Tables)

Accrued Expenses (Tables)	9 Months Ended
	Sep. 30, 2017
Payables and Accruals [Abstract]
Components of Accrued Expenses	Accrued expenses consisted of the following: September 30, December 31, Accrued Wages and Related Costs $ 169,047 $ 119,472 Accrued Officer Compensation 408,609 648,720 Accrued Professional Services 275,500 137,099 Accrued Warranty Obligations 114,056 41,132 Accrued Interest 183,553 375,560 Other Accrued Expenses 10,000 10,000 Total $ 1,160,765 $ 1,331,983
Changes in Accrued Warranty Obligations	The changes in the Company’s accrued warranty obligations for the nine months ended September 30, 2017 and the balance as of December 31, 2016 were as follows: Accrued Warranty Obligations at December 31, 2016 $ 41,132 Reductions for Settling Warranties (102,260) Warranties Issued During Period 175,184 Accrued Warranty Obligations at September 30, 2017 $ 114,056

Derivative Liability and Fair23

Derivative Liability and Fair Value Measurements (Tables)	9 Months Ended
	Sep. 30, 2017
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule Of Assets And Liabilities Measured At Fair Value On A Recurring Basis	We measure certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis are as follows at September 30, 2017: Total Level 1 Level 2 Level 3 Derivative Liability $ 122,533 $ — $ — $ 122,533 Total liabilities measured at fair value (Current liabilities) $ 122,533 $ — $ — $ 122,533 We measure certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis are as follows at December 31, 2016: Total Level 1 Level 2 Level 3 Derivative Liability $ 173,131 $ — $ — $ 173,131 Total liabilities measured at fair value (Long-Term) $ 173,131 $ — $ — $ 173,131
Schedule of Fair Value Level 3 warrant liabilities	Fair value – December 31, 2016 $ 173,131 Change in fair value for the period of warrant derivative liability (50,598) Fair value – September 30, 2017 $ 122,533
Schedule Of Fair Value Of Warrants	The Monte Carlo Options Lattice pricing model was used to estimate the fair value of the warrants outstanding: September 30, December 31, 2017 2016 Assumptions for Pricing Model: Expected term in years 0.85 1.22 Volatility range for years 61 % 100 % Risk-free interest rate 1.31 % 1.47 % Expected annual dividends None None Value of warrants outstanding: Fair value of warrants $ 122,533 $ 173,131

Long-Term Debt (Tables)

Long-Term Debt (Tables)	9 Months Ended
	Sep. 30, 2017
Debt Disclosure [Abstract]
Components of Long-Term Debt	Long-term debt consisted of the following: September 30, December 31, 2017 2016 Convertible, Senior Secured Notes payable. The principal was due June 3, 2017 and no payments were required prior to maturity. The notes carried a 5% annual interest rate, payable upon the notes’ maturity. Both the principal plus accrued interest were convertible into shares of the Company’s common stock at $2.25, subject to normal adjustments. The notes were secured by a first security position in all the assets of the Company. $ — $ 1,591,740 Convertible, Senior Secured Notes Debt Issuance Costs of $139,340, net of accumulated amortization. — (19,500) Unamortized debt discount related to derivative liability associated with above notes’ conversion price that was subject to adjustment in the event of subsequent equity sales at a lower purchase price (subject to certain exceptions). Upon issuance on June 3, 2014 the discount was $1,938,988. — (155,760) $ — $ 1,416,480 Less: Amount Due Within One Year — (1,416,480) Amount Due After One Year $ — $ —

Stock Warrants (Tables)

Stock Warrants (Tables)	9 Months Ended
	Sep. 30, 2017
Stockholders' Equity Note [Abstract]
Changes in Warrants	A summary of the various changes in warrants during the nine month period ended September 30, 2017 is as follows: Number of Warrants Warrants Outstanding at December 31, 2016 401,859 Exercised During the Period (250,009) Issued During the Period — Expired During the Period — Warrants Outstanding, September 30, 2017 151,850

Stock Based Compensation Plans

Stock Based Compensation Plans (Tables)	9 Months Ended
	Sep. 30, 2017
Stock Based Compensation Plans [Abstract]
Stock option plans	A summary of stock option activity for the nine months ended September 30, 2017 is as follows: Weighted Average Number of Exercise Options Price Outstanding at December 31, 2016 1,084,298 $ 4.76 Granted 427,500 6.00 Exercised (63,187) 2.89 Expired or Forfeited (30,802) 9.35 Outstanding at September 30, 2017 1,417,809 $ 5.00

Contractual Obligations (Tables

Contractual Obligations (Tables)	9 Months Ended
	Sep. 30, 2017
Commitments and Contingencies Disclosure [Abstract]
Contractual Payment Obligations for Operating Leases	Future minimum payments required under operating lease obligations as of September 30, 2017 are as follows: Total Minimum Lease Payments 2017 (3 months remaining) $ 93,053 2018 $ 348,900 2019 $ 341,990 2020 $ 307,311 2021 — Total $ 1,091,254

Basis of Presentation (Addition

Basis of Presentation (Additional Information (Detail) - USD ($)	1 Months Ended	3 Months Ended			9 Months Ended		12 Months Ended
	Aug. 14, 2017	Dec. 31, 2017	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016	Dec. 31, 2015
Basis Of Presentation [Line Items]
Net Income (Loss) Attributable To Parent			$ (5,502,242)	$ (5,035,861)	$ (13,754,038)	$ (12,915,091)	$ 19,250,082	$ 13,427,478
Retained Earnings Accumulated Deficit			(90,592,988)		(90,592,988)		(76,838,950)
Proceeds from Issuance Initial Public Offering							19,238,015
Sales Revenue Net			1,405,100	$ 582,549	3,941,025	1,507,266
Stock Issued During Period, Shares, New Issues	1,490,000
Shares Issued, Price Per Share	$ 5.75
Proceeds from Issuance of Common Stock	$ 7,978,321				8,567,500	$ 6,612,500
Subscription Receivable from Officer	$ 61,000		61,000		61,000		$ 0
Supply Commitment, Remaining Minimum Amount Committed			$ 5,000,000		$ 5,000,000
Chief Operating Officer [Member]
Basis Of Presentation [Line Items]
Stock Issued During Period, Shares, New Issues	10,000
Shares Issued, Price Per Share	$ 6.10
Scenario, Forecast [Member]
Basis Of Presentation [Line Items]
Sales Revenue Net		$ 221,000
Toshiba Japan [Member] | Sales Revenue, Net [Member]
Basis Of Presentation [Line Items]
Concentration Risk, Percentage					24.00%	0.00%
Toshiba Japan [Member] | Accounts Receivable [Member]
Basis Of Presentation [Line Items]
Concentration Risk, Percentage					59.00%	0.00%

Loss Per Share (Additional Info

Loss Per Share (Additional Information) (Detail)	9 Months Ended	12 Months Ended
	Sep. 30, 2017	Dec. 31, 2016
Earnings Per Share, Potentially Dilutive Securities	6,532,259	7,227,738

Inventories, Net (Components of

Inventories, Net (Components of Inventories) (Detail) - USD ($)	Sep. 30, 2017	Dec. 31, 2016
Inventory Disclosure [Line Items]
Purchased Parts and Components	$ 2,069,378	$ 1,990,026
Work in Process	212,444	454,120
Finished Goods	1,217,700	831,069
Less: Reserve for Obsolescence	(656,931)	(623,997)
Net	$ 2,842,591	$ 2,651,218

Inventories, Net (Additional In

Inventories, Net (Additional Information) (Detail) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Inventory Write-down	$ 1,151,482	$ 0	$ 1,151,482	$ 0

Accrued Expenses (Components of

Accrued Expenses (Components of Accrued Expenses) (Detail) - USD ($)	Sep. 30, 2017	Dec. 31, 2016
Accrued Liabilities [Line Items]
Accrued Wages and Related Costs	$ 169,047	$ 119,472
Accrued Officer Compensation	408,609	648,720
Accrued Professional Services	275,500	137,099
Accrued Warranty Obligations	114,056	41,132
Accrued Interest	183,553	375,560
Other Accrued Expenses	10,000	10,000
Total	$ 1,160,765	$ 1,331,983

Accrued Expenses (Changes in Ac

Accrued Expenses (Changes in Accrued Warranty Obligations) (Detail)	9 Months Ended
	Sep. 30, 2017USD ($)
Class Of Warrant Or Right [Line Items]
Accrued Warranty Obligations at December 31, 2016	$ 41,132
Reductions for Settling Warranties	(102,260)
Warranties Issued During Period	175,184
Accrued Warranty Obligations at September 30, 2017	$ 114,056

Accrued Expenses - Additional I

Accrued Expenses - Additional Information (Detail) - USD ($)	9 Months Ended
	Sep. 30, 2017	Dec. 31, 2016
Officers Compensation Payable Compounding Monthly Interest Rate	8.00%
Interest Payable, Current	$ 183,553	$ 141,645

Derivative Liability and Fair35

Derivative Liability and Fair Value Measurements (Schedule of Assets And Liabilities Measured At Fair Value On A Recurring Basis) (Detail) - USD ($)	Sep. 30, 2017	Dec. 31, 2016
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability	$ 122,533	$ 173,131
Total liabilities measured at fair value (Current liabilities)	122,533	173,131
Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability	0	0
Total liabilities measured at fair value (Current liabilities)	0	0
Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability	0	0
Total liabilities measured at fair value (Current liabilities)	0	0
Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability	122,533	173,131
Total liabilities measured at fair value (Current liabilities)	$ 122,533	$ 173,131

Derivative Liability and Fair36

Derivative Liability and Fair Value Measurements (Schedule of Fair Value Level 3 Warrant Liabilities) (Detail)	9 Months Ended
	Sep. 30, 2017USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value - December 31, 2016	$ 173,131
Change in fair value for the period of warrant derivative liability	(50,598)
Fair value - September 30, 2017	$ 122,533

Derivative Liability and Fair37

Derivative Liability and Fair Value Measurements (Estimate the fair value of warrants outstanding) (Detail) - Monte Carlo Options Lattice Pricing Model Warrants Outstanding - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2017	Dec. 31, 2016
Assumptions for Pricing Model:
Expected term in years	10 months 6 days	1 year 2 months 19 days
Volatility range for years	61.00%	100.00%
Risk-free interest rate	1.31%	1.47%
Expected annual dividends	0.00%	0.00%
Value of warrants outstanding:
Fair value of warrants	$ 122,533	$ 173,131

Derivative Liability and Fair38

Derivative Liability and Fair Value Measurements (Additional Information) (Detail) - USD ($)	Jun. 03, 2014	Sep. 30, 2017	Dec. 31, 2016	Dec. 31, 2014
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right		38,100	38,100
Convertible Debt				$ 3,000,000
Fair Value Of Debt Embedded Conversion Price Adjustment Option	$ 1,938,988
Percentage of Outstanding Warrants Issued By Parent		86.00%

Long-Term Debt (Components of L

Long-Term Debt (Components of Long-Term Debt) (Detail) - USD ($)	Sep. 30, 2017	Dec. 31, 2016
Debt Instrument [Line Items]
Long term debt	$ 0	$ 1,416,480
Less: Amount Due Within One Year	0	(1,416,480)
Amount Due After One Year	0	0
Convertible to shares of the Company's common shares at 2.25, subject to adjustment [Member]
Debt Instrument [Line Items]
Long term debt	0	1,591,740
Unamortized debt discount related to derivative liability associated with above Notes’ conversion price that was subject to adjustment in the event of subsequent equity sales at a lower purchase price (subject to certain exceptions). Upon issuance on June 3, 2014 the discount was $1,938,988 which is being amortized as interest expense over the life of the loan or sooner if the related debt is converted [Member]
Debt Instrument [Line Items]
Unamortized Debt Issuance Expense	0	(155,760)
Convertible, Senior Secured Notes Issued Debt Issuance Costs [Member]
Debt Instrument [Line Items]
Unamortized Debt Issuance Expense	$ 0	$ (19,500)

Long-Term Debt (Components of40

Long-Term Debt (Components of Long-Term Debt) (Parenthetical) (Detail) - USD ($)	Jun. 03, 2014	Sep. 30, 2017	Jun. 03, 2017
Debt Instrument [Line Items]
Fair Value Of Debt Embedded Conversion Price Adjustment Option	$ 1,938,988
Convertible, Senior Secured Notes Issued Debt Issuance Costs [Member]
Debt Instrument [Line Items]
Debt Issuance Costs, Net			$ 139,340
Convertible Senior Secured Notes payable [Member]
Debt Instrument [Line Items]
Long term debt, fixed interest repayment term		June 3, 2017
Long term debt, fixed interest rate		5.00%
Debt Instrument, Convertible, Conversion Price		$ 2.25

Long-Term Debt (Additional Info

Long-Term Debt (Additional Information) (Detail) - USD ($)	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Line of Credit Facility [Line Items]
Debt Conversion, Converted Instrument, Amount	$ 1,861,283	$ 342,034
Senior Secured Convertible Note [Member]
Line of Credit Facility [Line Items]
Debt Conversion, Converted Instrument, Amount	$ 269,543
Conversion of Stock, Shares Issued	119,797
Conversion of Stock, Shares Converted	707,440
Conversion of Stock, Amount Issued	$ 1,591,740

Capital Stock (Additional Infor

Capital Stock (Additional Information) (Detail) - USD ($)	Jan. 02, 2015	Aug. 14, 2017	Sep. 30, 2017	Dec. 31, 2016
Preferred Stock Shares Authorized			5,000,000	5,000,000
Stock Issued During Period, Shares, New Issues		1,490,000
Shares Issued, Price Per Share		$ 5.75
Stock Issued During Period, Value, New Issues			$ 8,628,500
Preferred Stock Shares Outstanding			49,626	49,626
Dividends Payable			$ 4,407,158	$ 3,134,129
Common Stock Shares Authorized			100,000,000	100,000,000
Common Stock Shares Issued			22,178,911	19,569,247
Common Stock Shares Outstanding			22,178,911	19,569,247
Common Stock, Par Or Stated Value Per Share			$ 0.001	$ 0.001
Chief Operating Officer [Member]
Stock Issued During Period, Shares, New Issues		10,000
Shares Issued, Price Per Share		$ 6.10
Public Offering [Member]
Stock Issued During Period, Shares, New Issues		1,500,000
Shares Issued, Price Per Share		$ 5.75
Stock Issued During Period, Value, New Issues		$ 7,978,321
Series A Preferred Stock [Member]
Conversion of Stock, Description			Each share of Series A Preferred Stock is convertible, at the option of the Series A holder, into 100 shares of the Company’s common stock (determined by dividing the Series A Original Issue Price of $500 by the Series A Conversion Price). The Series A Conversion Price is $5.00, subject to adjustment in the event of stock splits, dividends or other combinations.
Preferred Stock, Dividend Rate, Percentage			6.00%
Series A Preferred Stock [Member] | Corporation [Member]
Stock Issued During Period, Shares, New Issues	49,626
Shares Issued, Price Per Share	$ 500
Stock Issued During Period, Value, New Issues	$ 24,813,000

Stock Warrants (Changes in Warr

Stock Warrants (Changes in Warrants) (Detail)	9 Months Ended
	Sep. 30, 2017shares
Class Of Warrant Or Right [Line Items]
Warrants Outstanding at December 31, 2016	401,859
Exercised During the Period	(250,009)
Issued During the Period	0
Expired During the Period	0
Warrants Outstanding, September 30, 2017	151,850

Stock Warrants (Additional Info

Stock Warrants (Additional Information) (Detail)	9 Months Ended
	Sep. 30, 2017$ / shares
Class of Warrant or Right [Line Items]
Weighted average term of warrants	8 months 12 days
Weighted average exercise price of warrants per share	$ 2.66

Stock Based Compensation Plan45

Stock Based Compensation Plans (Summary of Stock Option Activity) (Detail) - Employee Stock Option [Member]	9 Months Ended
	Sep. 30, 2017$ / sharesshares
Number of Options
Outstanding, Beginning Balance | shares	1,084,298
Granted | shares	427,500
Exercised | shares	(63,187)
Expired or Forfeited | shares	(30,802)
Outstanding, Ending Balance | shares	1,417,809
Weighted Average Exercise Price
Outstanding, Beginning Balance | $ / shares	$ 4.76
Granted | $ / shares	6
Exercised | $ / shares	2.89
Expired or Forfeited | $ / shares	9.35
Outstanding, Ending Balance | $ / shares	$ 5

Stock Based Compensation Plan46

Stock Based Compensation Plans (Additional Information) (Detail) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]
Exercisable Options Outstanding Shares	716,046		716,046
Weighted average exercise price per share	$ 4.63		$ 4.63
Unvested Options Outstanding, Shares	701,763		701,763
Unvested Options Outstanding, Weighted average exercise price			$ 5.41
Unvested Options Outstanding Weighted average remaining life (yrs)			8 years 8 months 12 days
Weighted average remaining contractual term on unvested options			6 years 8 months 12 days
Unrecognized stock compensation expense	$ 3,512,000		$ 3,512,000
Weighted average recognition period			3 years
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term			7 years 8 months 12 days		7 years 7 months 6 days
Share-Based Compensation	425,000	$ 192,000	$ 912,102	$ 540,843
Executive Officer [Member]
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]
Unrecognized stock compensation expense	$ 531,000		$ 531,000
Weighted average recognition period			3 years 7 months 6 days
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested Issued , Number			100,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, NonVested in Period, Fair Value			$ 590,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value			$ 5.90

Contractual Obligations (Future

Contractual Obligations (Future Minimum Payments Required Under Operating Lease) (Detail)	Sep. 30, 2017USD ($)
Future Minimum Payments Required Under Operating Lease [Line Items]
2017 (3 months remaining)	$ 93,053
2,018	348,900
2,019	341,990
2,020	307,311
2,021	0
Total	$ 1,091,254

Contractual Obligations (Additi

Contractual Obligations (Additional Information) (Detail) - USD ($)	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Commitment Contingencies Disclosure [Line Items]
Lease Expiration Date	Oct. 3, 2020
Operating Leases, Rent Expense	$ 344,227	$ 371,239
Operating Lease Commencement Date	Oct. 3, 2015

Subsequent Events (Additional I

Subsequent Events (Additional Information) (Detail) - USD ($)	1 Months Ended	3 Months Ended		9 Months Ended
	Nov. 09, 2017	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Subsequent Event [Line Items]
Research and Development Expense		$ 1,506,307	$ 2,177,957	$ 4,374,202	$ 5,121,713
Subsequent Event [Member]
Subsequent Event [Line Items]
Research and Development Asset Acquired Other than Through Business Combination, Descriptions	the Company will pay approximately $75,702 as reimbursement of related patent applications to date. Further the Company will issue up to a total of 100,000 restricted shares of common stock as follows (i) 25,000 shares shall be issued upon the closing; (ii) a further 25,000 shares after the Company has successfully developed a working demonstrator system utilizing the IP; and (iii) 50,000 shares once the Company completes the successful commercialization of products containing the IP for sale in the marketplace.
Research and Development Expense	$ 200,000